CO logo

Global Cord Blood (CO) Selling, General & Administrative Expenses

CO Annual SG&A

$66.75 M
+$5.93 M+9.75%

31 March 2022

1-Year Change

+9.75%
CO annual selling, general & administrative expenses is up +9.75% year-on-year

3-Year Change

+10.73%
CO annual selling, general & administrative expenses is up +10.73% over the past 3 years

All-time High

$70.10 M
CO annual selling, general & administrative expenses is currently -4.78% below its historical high of $70.10 million
Annual Total Expenses$98.76 M
CO annual total expenses is $98.76 million
Annual Operating Expenses$70.22 M
CO annual total operating expenses is $70.22 million
Annual Revenue$193.54 M
CO annual revenue is $193.54 million
Annual Net Income$78.00 M
CO annual net profit is $78.00 million

CO Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CO Quarterly SG&A

$17.04 M
-$673.10 K-3.80%

31 March 2022

1-Year Change

+7.67%
CO quarterly selling, general & administrative expenses is up +7.67% year-on-year

3-Year Change

+3.84%
CO quarterly selling, general & administrative expenses is up +3.84% over the past 3 years

All-time High

$22.49 M
CO quarterly selling, general & administrative expenses is currently -24.24% below its historical high of $22.49 million
Quarterly Total Expenses$24.40 M
CO quarterly total expenses is $24.40 million
Quarterly Operating Expenses$17.79 M
CO quarterly total operating expenses is $17.79 million
Quarterly Revenue$46.76 M
CO quarterly revenue is $46.76 million
Quarterly Net Income$16.47 M
CO quarterly net profit is $16.47 million

CO Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CO TTM SG&A

$1.69 B
+$91.60 M+5.73%

31 March 2022

1-Year Change

+2675.63%
CO TTM selling, general & administrative expenses is up +2675.63% year-on-year

3-Year Change

+2441.92%
CO TTM selling, general & administrative expenses is up +2441.92% over the past 3 years

All-time High

$71.01 M
Annual Total Expenses$98.76 M
CO annual total expenses is $98.76 million
Annual Operating Expenses$70.22 M
CO annual total operating expenses is $70.22 million
TTM Revenue$193.54 M
CO TTM revenue is $193.54 million
TTM Net Income$77.97 M
CO TTM net profit is $77.97 million

CO TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CO Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.8%+7.7%+2675.6%
3 y3 years+10.7%+3.8%+2441.9%
5 y5 years+22.2%+15.7%+2441.9%

CO Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-4.8%-24.2%+2280.0%

Global Cord Blood Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Mar 2022
$66.75 M(+9.8%)
$17.04 M(-3.8%)
$66.77 M(+1.9%)
Dec 2021
-
$17.71 M(+13.1%)
$65.56 M(+1.0%)
Sept 2021
-
$15.66 M(-4.2%)
$64.88 M(+2.7%)
June 2021
-
$16.36 M(+3.3%)
$63.20 M(+3.8%)
Mar 2021
$60.82 M(-6.3%)
$15.83 M(-7.1%)
$60.89 M(+1.7%)
Dec 2020
-
$17.04 M(+21.9%)
$59.89 M(-0.9%)
Sept 2020
-
$13.98 M(-0.5%)
$60.43 M(-3.7%)
June 2020
-
$14.05 M(-5.2%)
$62.74 M(-3.3%)
Mar 2020
$64.92 M(+7.7%)
$14.82 M(-15.7%)
$64.90 M(-2.4%)
Dec 2019
-
$17.58 M(+7.9%)
$66.49 M(+2.7%)
Sept 2019
-
$16.29 M(+0.6%)
$64.77 M(+4.6%)
June 2019
-
$16.20 M(-1.3%)
$61.92 M(+2.8%)
Mar 2019
$60.28 M(-14.0%)
$16.41 M(+3.5%)
$60.23 M(-9.2%)
Dec 2018
-
$15.86 M(+18.0%)
$66.31 M(-2.7%)
Sept 2018
-
$13.44 M(-7.4%)
$68.11 M(-4.1%)
June 2018
-
$14.51 M(-35.5%)
$71.01 M(+1.2%)
Mar 2018
$70.10 M(+28.3%)
$22.49 M(+27.3%)
$70.17 M(+12.4%)
Dec 2017
-
$17.67 M(+8.1%)
$62.41 M(+6.0%)
Sept 2017
-
$16.34 M(+19.5%)
$58.89 M(+5.7%)
June 2017
-
$13.67 M(-7.2%)
$55.74 M(+2.2%)
Mar 2017
$54.63 M(+9.2%)
$14.73 M(+4.1%)
$54.53 M(+4.7%)
Dec 2016
-
$14.15 M(+7.3%)
$52.06 M(+3.3%)
Sept 2016
-
$13.19 M(+5.8%)
$50.40 M(+1.1%)
June 2016
-
$12.46 M(+1.6%)
$49.85 M(-0.3%)
Mar 2016
$50.02 M(+19.4%)
$12.26 M(-1.8%)
$50.02 M(+0.0%)
Dec 2015
-
$12.49 M(-1.1%)
$50.00 M(+5.7%)
Sept 2015
-
$12.63 M(-0.0%)
$47.33 M(+5.8%)
June 2015
-
$12.64 M(+3.2%)
$44.75 M(+6.9%)
Mar 2015
$41.89 M
$12.24 M(+24.7%)
$41.88 M(+7.0%)
Dec 2014
-
$9.81 M(-2.3%)
$39.15 M(+1.9%)
Sept 2014
-
$10.05 M(+2.9%)
$38.43 M(+2.6%)
DateAnnualQuarterlyTTM
June 2014
-
$9.77 M(+2.7%)
$37.47 M(+1.9%)
Mar 2014
$36.76 M(+14.7%)
$9.51 M(+4.6%)
$36.77 M(+2.8%)
Dec 2013
-
$9.10 M(+0.1%)
$35.78 M(+2.3%)
Sept 2013
-
$9.09 M(+0.2%)
$34.97 M(+2.5%)
June 2013
-
$9.07 M(+6.4%)
$34.14 M(+6.5%)
Mar 2013
$32.04 M(+35.5%)
$8.53 M(+2.8%)
$32.05 M(+7.5%)
Dec 2012
-
$8.29 M(+0.5%)
$29.80 M(+7.4%)
Sept 2012
-
$8.25 M(+18.1%)
$27.74 M(+9.9%)
June 2012
-
$6.98 M(+11.3%)
$25.25 M(+6.7%)
Mar 2012
$23.64 M(+21.0%)
$6.28 M(+0.8%)
$23.65 M(+3.2%)
Dec 2011
-
$6.23 M(+8.1%)
$22.92 M(+6.1%)
Sept 2011
-
$5.76 M(+6.9%)
$21.61 M(+4.7%)
June 2011
-
$5.39 M(-2.8%)
$20.64 M(+5.4%)
Mar 2011
$19.54 M(+43.7%)
$5.54 M(+12.8%)
$19.58 M(+10.7%)
Dec 2010
-
$4.91 M(+2.4%)
$17.69 M(+5.6%)
Sept 2010
-
$4.80 M(+11.0%)
$16.75 M(+10.2%)
June 2010
-
$4.32 M(+18.4%)
$15.19 M(+11.7%)
Mar 2010
$13.60 M(+742.1%)
$3.65 M(-8.0%)
$13.60 M(+32.9%)
Dec 2009
-
$3.97 M(+22.5%)
$10.23 M(+38.1%)
Sept 2009
-
$3.24 M(+18.8%)
$7.41 M(+66.5%)
June 2009
-
$2.73 M(+846.2%)
$4.45 M(+144.1%)
Mar 2009
-
$288.50 K(-74.9%)
$1.82 M(+8.3%)
Dec 2008
$1.61 M(+206.1%)
$1.15 M(+303.8%)
$1.68 M(+156.6%)
Sept 2008
-
$284.40 K(+179.1%)
$655.90 K(+29.0%)
June 2008
-
$101.90 K(-31.3%)
$508.40 K(-10.6%)
Mar 2008
-
$148.30 K(+22.3%)
$568.70 K(+5.3%)
Dec 2007
$527.50 K(+6255.4%)
$121.30 K(-11.4%)
$540.00 K(+29.0%)
Sept 2007
-
$136.90 K(-15.6%)
$418.70 K(+48.6%)
June 2007
-
$162.20 K(+35.6%)
$281.80 K(+135.6%)
Mar 2007
-
$119.60 K
$119.60 K
Dec 2006
$8300.00
-
-

FAQ

  • What is Global Cord Blood annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Global Cord Blood?
  • What is Global Cord Blood annual SG&A year-on-year change?
  • What is Global Cord Blood quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Global Cord Blood?
  • What is Global Cord Blood quarterly SG&A year-on-year change?
  • What is Global Cord Blood TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Global Cord Blood?
  • What is Global Cord Blood TTM SG&A year-on-year change?

What is Global Cord Blood annual selling, general & administrative expenses?

The current annual SG&A of CO is $66.75 M

What is the all time high annual SG&A for Global Cord Blood?

Global Cord Blood all-time high annual selling, general & administrative expenses is $70.10 M

What is Global Cord Blood annual SG&A year-on-year change?

Over the past year, CO annual selling, general & administrative expenses has changed by +$5.93 M (+9.75%)

What is Global Cord Blood quarterly selling, general & administrative expenses?

The current quarterly SG&A of CO is $17.04 M

What is the all time high quarterly SG&A for Global Cord Blood?

Global Cord Blood all-time high quarterly selling, general & administrative expenses is $22.49 M

What is Global Cord Blood quarterly SG&A year-on-year change?

Over the past year, CO quarterly selling, general & administrative expenses has changed by +$1.21 M (+7.67%)

What is Global Cord Blood TTM selling, general & administrative expenses?

The current TTM SG&A of CO is $1.69 B

What is the all time high TTM SG&A for Global Cord Blood?

Global Cord Blood all-time high TTM selling, general & administrative expenses is $71.01 M

What is Global Cord Blood TTM SG&A year-on-year change?

Over the past year, CO TTM selling, general & administrative expenses has changed by +$1.63 B (+2675.63%)